VM-PATHI Correlates With Cognitive Function Improvement After Successful Treatment in Patients With Vestibular Migraine.

Autor:	Patel EJ; Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco., Hum M; Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco., Gardi A; Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco., Steenerson KK; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Palo Alto, California., Rizk HG; Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina., Sharon JD; Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco.
Jazyk:	angličtina
Zdroj:	Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology [Otol Neurotol] 2023 Sep 01; Vol. 44 (8), pp. 813-816. Date of Electronic Publication: 2023 Jul 29.
DOI:	10.1097/MAO.0000000000003976
Abstrakt:	Objective: To assess changes in cognitive function in vestibular migraine patients undergoing treatment. Study Design: Prospective cohort. Setting: Single-institution tertiary-care center. Patients: Thirty-four patients with vestibular migraine were included in the study. Average age at diagnosis was 47.9 years. A majority of patients (91.2%) were female. Interventions: Vestibular therapies included pharmacologic treatment (67.6%), mindfulness-based stress reduction (58.8%), vestibular physical therapy (20.6%), and lifestyle changes only (2.9%). Main Outcome Measures: Pretreatment and posttreatment questionnaires were collected including the Cognitive Failures Questionnaire (CFQ), Vestibular Migraine Patient Assessment Tool and Handicap Inventory (VM-PATHI), and Dizziness Handicap Inventory. Results: Median time between pretreatment and posttreatment questionnaire was 4.4 months (range, 2.8-15.6. mo). CFQ scores decreased in subjects who responded to treatment, as defined by those with a positive change in VM-PATHI score (average decrease, 6.5; p = 0.03). CFQ scores did not improve in subjects who had no improvement in their vestibular condition, as defined by no change or an increase in VM-PATHI score (average increase, 2.0; p = 0.53). Univariate linear regression showed that VM-PATHI score change was highly predictive of CFQ change ( p < 0.01, r2 = 0.36). Multivariate regression demonstrated that the VM-PATHI ( p = 0.03) and not the Dizziness Handicap Inventory ( p = 0.10) predicted changes in CFQ score. Conclusions: Self-reported cognitive dysfunction improves with successful treatment of vestibular migraine. Competing Interests: The authors disclose no conflicts of interest. (Copyright © 2023, Otology & Neurotology, Inc.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu